Details

Autor(en) / Beteiligte

• Chan, Siew Pheng
• Mumtaz, Malik
• Ratnasingam, Jeyakantha
• Tan, Alexander Tong Boon
• Lim, Siang Chin
• Rosman, Azhari
• Chee, Kok Han
• Lim, Soo Kun
• Yew, Shiong Shiong
• Mohd Yusof, Barakatun-Nisak
• Lau, Bik Kui
• Kassim, Saiful Bahari
• Mohamed, Mafauzy

Titel

Practical guide in using insulin degludec/insulin aspart: A multidisciplinary approach in Malaysia

Ist Teil von

• Malaysian family physician, 2023, Vol.18, p.31-12

Ort / Verlag

Kuala Lumpur: Academy of Family Physicians of Malaysia

Erscheinungsjahr

2023

Quelle

EZB Free E-Journals

Beschreibungen/Notizen

• Insulin degludec/insulin aspart (IDegAsp) co-formulation provides both basal and mealtime glycaemic control in a single injection. The glucose level-lowering efficacy of IDegAsp is reported to be superior or non-inferior to that of the currently available insulin therapies with a lower rate of overall hypoglycaemia and nocturnal hypoglycaemia. An expert panel from Malaysia aims to provide insights into the utilisation of IDegAsp across a broad range of patients with type 2 diabetes mellitus (i.e. treatment-naïve or insulin-naïve patients or patients receiving treatment intensification from basal-only regimens, premixed insulin and basal–bolus insulin therapy). IDegAsp can be initiated as once-daily dosing for the main meal with the largest carbohydrate content with weekly dose adjustments based on patient response. A lower starting dose is recommended for patients with cardiac or renal comorbidities. Dose intensification with IDegAsp may warrant splitting into twice-daily dosing. IDegAsp twice-daily dosing does not need to be split at a 50:50 ratio but should be adjusted to match the carbohydrate content of meals. The treatment of patients choosing to fast during Ramadan should be switched to IDegAsp early before Ramadan, as a longer duration of titration leads to better glycated haemoglobin level reductions. The pre-Ramadan breakfast/lunch insulin dose can be reduced by 30%–50% and taken during sahur, while the pre-Ramadan dinner dose can be taken without any change during iftar. Education on the main meal concept is important, as carbohydrates are present in almost all meals. Patients should not have a misconception of consuming more carbohydrates while taking IDegAsp.